Release Date: 25/10/12 11:05 Summary: Change of Director's Interest Notice Price Sensitive: No Download Document 279.62KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%